Active Shortage

APO-ENZALUTAMIDE

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-ENZALUTAMIDE in Canada?

Yes. APO-ENZALUTAMIDE 40MG has an active shortage reported to Health Canada (last updated November 12, 2026).

Why is APO-ENZALUTAMIDE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-ENZALUTAMIDE be available again?

The manufacturer's estimated resolution date is January 8, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file4 products

Expected resolution~2 months remaining (estimate)

Affected strength40MG

Report last updated2026-11-12

Checked by MedShort2026-11-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

XTANDI

ASTELLAS PHARMA CANADA INC

40MG · DIN 02407329

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

JAMP ENZALUTAMIDE

JAMP PHARMA CORPORATION

40MG · DIN 02515229

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

REDDY-ENZALUTAMIDE

DR REDDY'S LABORATORIES LTD

40MG · DIN 02558424

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

AURO-ENZALUTAMIDE

AURO PHARMA INC

40MG · DIN 02494736

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2027-01-08

~2 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02562677

Strength

40MG

Dosage Form

CAPSULE

Route

ORAL

Active Ingredient

ENZALUTAMIDE

Tier

Unrated

Last Updated

2026-11-12

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244